Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.64B | $3.84B | $3.88B | $3.81B | $3.63B | $4.19B | $4.72B | $4.98B | $5.34B | $5.20B |
| Revenue growth | — | 5.4% | 1.2% | -2.0% | -4.5% | 15.4% | 12.5% | 5.6% | 7.2% | -2.7% |
| Gross profit | $1.08B | $1.13B | $1.11B | $1.08B | $1.04B | $1.19B | $1.28B | $1.55B | $1.78B | $1.73B |
| Gross margin | 29.6% | 29.3% | 28.6% | 28.4% | 28.6% | 28.3% | 27.2% | 31.1% | 33.3% | 33.4% |
| Operating income | $429M | $495M | $510M | $657M | $479M | $590M | $656M | $792M | $1.04B | $1.04B |
| Operating margin | 11.8% | 12.9% | 13.1% | 17.3% | 13.2% | 14.1% | 13.9% | 15.9% | 19.5% | 20.0% |
| Net income | $278M | $306M | $359M | $409M | $356M | $464M | $497M | $591M | $811M | $806M |
| Net margin | 7.6% | 8.0% | 9.2% | 10.7% | 9.8% | 11.1% | 10.5% | 11.9% | 15.2% | 15.5% |
| EPS (diluted) | $6.32 | $7.14 | $8.74 | $10.38 | $9.24 | $12.39 | $13.88 | $16.58 | $22.66 | $22.79 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $374M | $325M | $496M | $396M | $612M | $516M | $302M | $736M | $946M | $758M |
| Capital expenditures | $84.3M | $98.3M | $95.2M | $106M | $78.5M | $107M | $101M | $250M | $164M | $119M |
| Free cash flow | $290M | $227M | $400M | $291M | $534M | $409M | $201M | $486M | $782M | $639M |
| Share buybacks | $300M | $250M | $450M | $400M | $100M | $600M | $300M | $0.00 | $53.6M | $482M |
| Dividends paid | $69.0M | $79.7M | $93.9M | $111M | $118M | $127M | $142M | $153M | $160M | $173M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $50.2M | $68.2M | $46.3M | $37.3M | $124M | $31.0M | $52.6M | $60.7M | $415M | $34.2M |
| Total assets | $1.76B | $1.89B | $1.82B | $2.03B | $2.03B | $2.17B | $2.57B | $2.94B | $3.62B | $4.08B |
| Total liabilities | $1.72B | $1.84B | $1.97B | $2.21B | $2.05B | $2.44B | $2.77B | $2.55B | $2.66B | $2.92B |
| Shareholders' equity | $38.0M | $50.1M | -$150M | -$170M | -$17.1M | -$269M | -$203M | $393M | $962M | $1.16B |
| Retained earnings | $1.35B | $1.58B | $1.85B | $2.15B | $2.39B | $2.72B | $3.07B | $3.61B | $4.26B | $4.89B |
| Shares (wtd avg diluted) | 44.0M | 42.8M | 41.1M | 39.4M | 38.6M | 37.5M | 35.8M | 35.7M | 35.8M | 35.4M |
Every figure is extracted from LENNOX INTERNATIONAL INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.